Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
ORGANIZATION
Enhertu, Dupixent Win 2026 International Prix Galien Biotechnology Award
Daiichi Sankyo and AstraZeneca’s antibody drug conjugate (ADC) Enhertu (trastuzumab deruxtecan) and Regeneron and Sanofi’s Dupixent (dupilumab) have both won the Best Biotechnology Product award at the 2026 International Prix Galien. The awards were presented on October 29 in New…
To read the full story
Related Article
- Prix Galien to Launch Japan Awards in February 2027
September 8, 2026
ORGANIZATION
- PhRMA Japan Chief Laments CEA Expansion, Calls for Sweeping Reform
November 20, 2026
- Ex-MHLW Bureau Chief Jo Joins Patient Support Foundation
November 20, 2026
- JPMA, EFPIA Follow PhRMA in Decrying CEA Price Cut Expansion
November 19, 2026
- PhRMA Slams CEA Expansion, Warns It Undermines Japan Growth Strategy
November 17, 2026
- UCB Japan President Kikuchi to Take Helm of EFPIA Japan
November 13, 2026





